Form 4 for EVH Evolent Health, Inc.
Accepted 2024-08-26 00:00:00 ET · period of report 2024-08-22 · accession 0001628908-24-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-26 | 2024-08-22 | EVH | Blackley Seth | CEO, Dir | M - OptEx | $8.46 | +187.9K | 599.8K | +46% | +$1.59M |
| D | 2024-08-26 | 2024-08-22 | EVH | Blackley Seth | CEO, Dir | S - Sale+OE | $30.00 | -187.9K | 411.9K | -31% | -$5.64M |
| DM | 2024-08-26 | 2024-08-22 | EVH | Blackley Seth | CEO, Dir | M - OptEx | $0.00 | -187.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-08-22 | M | A | 100,000 | $6.87 | 511,924 | D | — | — | (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. (F3) Since the date of the reporting person's last ownership report, Mr. Blackley transferred 348,458 shares of Evolent Health, Inc. Class A Common Stock pursuant to a domestic relations order. Mr. Blackley no longer reports as beneficially owned any securities owned by his ex-spouse. |
| 2 | Common | Class A Common Stock | 2024-08-22 | M | A | 35,162 | $10.27 | 547,086 | D | — | — | (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Common | Class A Common Stock | 2024-08-22 | M | A | 52,742 | $10.27 | 599,828 | D | — | — | (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 4 | Common | Class A Common Stock | 2024-08-22 | S | D | 187,904 | $30.00 | 411,924 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 5 | Derivative | Class A Common Stock Option (right to buy) | 2024-08-22 | M | D | 35,162 | $0.00 | 0 | D | $10.27 · — to 2026-03-01 | 35,162 Class A Common Stock | (F6) The Class A Common Stock Options exercised vested on March 1, 2019 and March 1, 2020. |
| 6 | Derivative | Class A Common Stock Option (right to buy) | 2024-08-22 | M | D | 100,000 | $0.00 | 0 | D | $6.87 · — to 2025-02-01 | 100,000 Class A Common Stock | (F5) The Class A Common Stock Options exercised vested on February 1, 2019. |
| 7 | Derivative | Class A Common Stock Option (right to buy) | 2024-08-22 | M | D | 52,742 | $0.00 | 0 | D | $10.27 · — to 2026-03-01 | 52,742 Class A Common Stock | (F7) The Class A Common Stock Options exercised vested on March 1, 2020. |